{
    "organizations": [],
    "uuid": "cd6f1ffc297a06b2e2b3fbf9d0159f863b917f9b",
    "author": "Reuters Editorial",
    "url": "https://www.reuters.com/article/brief-ose-immunotherapeutics-appoints-al/brief-ose-immunotherapeutics-appoints-alexis-peyroles-ceo-idUSFWN1RP0W3",
    "ord_in_thread": 0,
    "title": "BRIEF-OSE Immunotherapeutics Appoints Alexis Peyroles CEO",
    "locations": [],
    "highlightText": "",
    "language": "english",
    "persons": [],
    "text": "April 12 (Reuters) - OSE IMMUNOTHERAPEUTICS SA:\n* OSE IMMUNOTHERAPEUTICS ANNOUNCES EVOLUTION IN COMPANY’S BOARD OF DIRECTORS AND MANAGEMENT\n* DOMINIQUE COSTANTINI, MD, APPOINTED AS CHAIRMAN OF COMPANY’S BOARD OF DIRECTORS\n* ALEXIS PEYROLES APPOINTED AS CHIEF EXECUTIVE OFFICER * CHANGES EFFECTIVE IMMEDIATELY Source text for Eikon: Further company coverage: (Gdynia Newsroom)\n ",
    "published": "2018-04-13T00:41:00.000+03:00",
    "crawled": "2018-04-13T17:38:22.003+03:00",
    "highlightTitle": "",
    "preprocessed_text": [
        "april",
        "reuters",
        "ose",
        "immunotherapeutics",
        "sa",
        "ose",
        "immunotherapeutics",
        "announces",
        "evolution",
        "company",
        "board",
        "director",
        "management",
        "dominique",
        "costantini",
        "md",
        "appointed",
        "chairman",
        "company",
        "board",
        "director",
        "alexis",
        "peyroles",
        "appointed",
        "chief",
        "executive",
        "officer",
        "change",
        "effective",
        "immediately",
        "source",
        "text",
        "eikon",
        "company",
        "coverage",
        "gdynia",
        "newsroom"
    ]
}